MedPath

Nimenrix Powder and Solvent for Solution for Injection

Registration Number: MAL13085066ACZ

Approved
Approval ID

0d2f7f8d3e16b68a

Registration Number

MAL13085066ACZ

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types2 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (2)

2 mlAvailable
Package Size: 2 ml
Status: NPRA Approved
1.25ml mLAvailable
Package Size: 1.25ml mL
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (4)

meningococcus A, purified polysaccharides antigenActive
Monograph: meningococcus a, purified polysaccharides antigen
meningococcus W135, purified polysaccharides antigenActive
Monograph: meningococcus w 135, purified polysaccharides antigen
meningococcus y, purified polysaccharides antigenActive
Monograph: meningococcus y, purified polysaccharides antigen
meningococcus C, purified polysaccharides antigen conjugatedActive
Monograph: meningococcus c, purified polysaccharides antigen conjugated

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Nimenrix Powder and Solvent for Solution for Injection - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform